• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GTH
Click for more information
0.00% 1.8¢

GATHID LTD - Corporate Spotlight

Market Cap $4.743M  ! watchlist Created with Sketch. Add to my watchlist
Technology Software - Infrastructure

Gathid Ltd, formerly RightCrowd Limited, is an Australia-based company, which specializes... Gathid Ltd, formerly RightCrowd Limited, is an Australia-based company, which specializes in technology solutions. The Company operates through the Access Analytics segment. The Access Analytics segment is engaged in the development and delivery of analytics software for identifying user access compliance issues. RightCrowd Access Analytics is a software solution that allows HR, IT, OT, security teams and business personnel to easily collaborate, review and take action against inappropriate access from any assets and enterprise systems in a single view. RightCrowd Access Analytics identifies people with inappropriate access from HR and IT systems to physical access control systems, regardless of the technology mix in place. Based on daily input feeds from business systems, people systems and physical access control, it flags incorrect or out of date identities and access permissions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
1.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.743M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
GTH (ASX) Chart

Top Stories

UNITH's digital humans expand into Amazon; Facebook

AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.